Table 3.

Follow-up blood counts, in chronological order, after discontinuation of treatment with lenalidomide

10/7/201311/4/201312/23/20131/20/20142/17/20149/12/2016
White blood cells, × 109/L 3.42 (L) 4.32 9.22 7.67 8.05 7.95 
Red blood cells, × 1012/L 2.65 (L) 2.72 (L) 4.40 (L) 4.58 4.60 4.30 
Hemoglobin, g/dL 9.1 (L) 9.9 (L) 15.0 15.1 14.5 12.9 
Hematocrit, % 28.8 (L) 31.1 (L) 47.5 47.3 45.9 40.7 
MCV, fL 108.7 (H) 114.3 (H) 108.0 (H) 103.3 (H) 99.8 92.9 
MCH, pg 34.3 (H) 36.4 (H) 34.1 (H) 33.0 31.5 29.5 
MCHC, g/dL 31.6 31.8 31.6 31.9 31.6 31.7 
RDW, % 16.9 (H) 19.3 (H) 13.7 13.2 13.3 14.8 
Platelets, × 109/L 119 (L) 181 137 (L) 136 (L) 126 (L) 139 
Neutrophils, × 109/L 1.78 (L) 2.47 6.53 4.96 5.05 5.34 
Immature granulocytes, × 109/L 0.01 0.02 0.02 0.02 0.02 0.02 
Lymphocytes, × 109/L 1.28 1.59 1.89 1.97 2.21 1.79 
Monocytes, × 109/L 0.35 0.20 0.67 0.54 0.63 0.56 
Eosinophils, × 109/L 0.00 0.03 0.09 0.15 0.11 0.21 
Basophils, × 109/L 0.00 0.01 0.02 0.03 0.03 0.03 
10/7/201311/4/201312/23/20131/20/20142/17/20149/12/2016
White blood cells, × 109/L 3.42 (L) 4.32 9.22 7.67 8.05 7.95 
Red blood cells, × 1012/L 2.65 (L) 2.72 (L) 4.40 (L) 4.58 4.60 4.30 
Hemoglobin, g/dL 9.1 (L) 9.9 (L) 15.0 15.1 14.5 12.9 
Hematocrit, % 28.8 (L) 31.1 (L) 47.5 47.3 45.9 40.7 
MCV, fL 108.7 (H) 114.3 (H) 108.0 (H) 103.3 (H) 99.8 92.9 
MCH, pg 34.3 (H) 36.4 (H) 34.1 (H) 33.0 31.5 29.5 
MCHC, g/dL 31.6 31.8 31.6 31.9 31.6 31.7 
RDW, % 16.9 (H) 19.3 (H) 13.7 13.2 13.3 14.8 
Platelets, × 109/L 119 (L) 181 137 (L) 136 (L) 126 (L) 139 
Neutrophils, × 109/L 1.78 (L) 2.47 6.53 4.96 5.05 5.34 
Immature granulocytes, × 109/L 0.01 0.02 0.02 0.02 0.02 0.02 
Lymphocytes, × 109/L 1.28 1.59 1.89 1.97 2.21 1.79 
Monocytes, × 109/L 0.35 0.20 0.67 0.54 0.63 0.56 
Eosinophils, × 109/L 0.00 0.03 0.09 0.15 0.11 0.21 
Basophils, × 109/L 0.00 0.01 0.02 0.03 0.03 0.03 

Dates are given in month/day/year format. The last column is at the time of the repeat bone marrow biopsy.

or Create an Account

Close Modal
Close Modal